Geode Capital Management
GRCL

Geode Capital Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Geode Capital Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
2023
Q4 		$435K Hold
2023
Q3 		$125K Buy
2023
Q2 		$142K Buy
2023
Q1 		$61.7K Hold
2022
Q4 		$76K Hold
2022
Q3 		$106K Hold
2022
Q2 		$182K Hold
2022
Q1 		$77K Buy
2021
Q4 		$157K Buy